Question 1

What is Tomas Lorant?

Accepted Answer

Tomas Lorant is a Person.

Question 2

How often does Tomas Lorant appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Tomas Lorant first tracked by Ergen?

Accepted Answer

First tracked on May 27, 2026.

Question 4

When was Tomas Lorant last mentioned in news?

Accepted Answer

Last active on May 27, 2026.

Question 5

What is Tomas Lorant's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Tomas Lorant in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Tomas Lorant?

Accepted Answer

Hansa Biopharma Idefirix PAES Results (May 27, 2026, 6 articles).

Question 8

How did the "Hansa Biopharma Idefirix PAES Results" event impact Tomas Lorant?

Accepted Answer

As the coordinating investigator for the PAES study, Tomas Lorant confirmed the key role of imlifidase in transforming transplantation care for highly sensitized patients.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.